Alterations in myocardial cytoskeletal and regulatory protein expression following a single doxorubicin injection

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 5, 2003, Pages 788-794

  Dudnakova, Tatyana V ^c   Lakomkin, Vladimir L ^c   Tsyplenkova, Valerie G ^b   Shekhonin, Boris V ^c   Shirinsky, Vladimir P ^c   Kapelko, Valeri I ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b Clinical Cardiology   (Russian Federation)

^c NONE

Author keywords

Cardiac injury; Doxorubicin; Extracellular matrix; Fibrosis; Kinase related protein; Myosin light chain kinase

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; DESMIN; DOXORUBICIN; FIBRONECTIN; KINASE RELATED PROTEIN; MYOSIN LIGHT CHAIN KINASE; PROTEIN; REGULATOR PROTEIN; SCLEROPROTEIN; TELOKIN; TUBULIN; UNCLASSIFIED DRUG; VINCULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHICKEN; CONCENTRATION RESPONSE; CYTOSKELETON; DRUG MECHANISM; ELECTRON MICROSCOPY; HEART MUSCLE; IMMUNOBLOTTING; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; ULTRASTRUCTURE;

ANIMALS; CALCIUM-BINDING PROTEINS; CARDIOMYOPATHIES; CELLS, CULTURED; CHICK EMBRYO; CYTOSKELETAL PROTEINS; DOXORUBICIN; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; HEART VENTRICLES; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KINESIN; MALE; MICROSCOPY, ELECTRON; MUSCLE PROTEINS; MYOCYTES, CARDIAC; MYOSIN-LIGHT-CHAIN KINASE; PEPTIDES; RATS; RATS, WISTAR;

EID: 0242584390     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200305000-00017     Document Type: Article

References (42)

1. Singal PK, Deally CMR, Weinberg LE. Subcellular effects of adriamycin in the heart: a concise review. J Mol Cell Cardiol. 1987;19:817-28.
2. Olson RD, Mushlin PS. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 1990;4:3076-86.
3. Singal PK, Iliskovic N, Li T, et al. Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J. 1997;11:931-6.
4. Caulfield JB, Wolkowicz PE. Myocardial connective tissue alterations. Toxicol Pathol. 1990;18:488-96.
5. Sanchez-Quintana D, Climent V, Garcia-Martinez V, et al. Extracellular matrix arrangement in the papillary muscles of the adult rat heart: alterations after doxorubicin administration and experimental hypertension. Basic Res Cardiol. 1994;89:279-92.
6. Gille L, Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic Biol Med. 1997;23:775-82.
7. Arola OJ, Saraste A, Pulkki K, et al. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 2000;60:1789-92.
8. Papoian T, Lewis W. Adriamycin cardiotoxicity in vivo: selective alterations in rat cardiac mRNAs. Am J Pathol. 1990;136:1201-7.
9. Boucek RJ Jr, Miracle A, Anderson M, et al. Persistent effects of doxorubicin on cardiac gene expression. J Mol Cell Cardiol. 1999;31:1435-46.
10. Kapelko VI, Tsyplenkova VG, Khatkevich AN, et al. Morphological and functional estimation of acute and protracted cardiomyocyte alterations caused by adriamycin in varied doses. Exp Clin Cardiol. 1999;4:35-42.
11. Birukov KG, Schavocky JP, Shirinsky VP, et al. Organization of the genetic locus for chicken MLCK is complex: proteins are incoded and exhibit differential expression and localization. J Cell Biochem. 1998;70:402-13.
12. Shirinsky VP, Vorotnikov AV, Birukov KG, et al. KRP stabilizes unphosphorylated smooth muscle myosin minifilaments in presence of ATP. J Biol Chem. 1993;268:16578-83.
13. Silver DL, Vorotnikov AV, Watterson DM, et al. Sites of interaction between kinase-related protein and smooth muscle myosin. J Biol Chem. 1997;272:25353-9.
14. Watterson DM, Schavocky JP, Gou L, et al. Analysis of KRP gene found at human chromosome 3q21 in multi-gene cluster: organization, expression, alternative splicing, and polymorphic marker. J Cell Biochem. 1999;75:481-91.
15. Mettler FP, Young DM, Ward JM. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats. Cancer Res. 1977;37:2705-13.
16. Olson HM, Capen CC. Chronic cardiotoxicity of doxorubicin (adriamycin) in the rat: morphologic and biochemical investigations. Toxicol Appl Pharmacol. 1978;44:605-16.
17. Eschenhagen T, Fink C, Remmers U, et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 1997;11:683-94.
18. Maisch B, Gregor O, Zeuss M, et al. Acute effect of calcium channel blockers on adriamycin exposed isolated adult cardiocytes. Basic Res Cardiol. 1985;80:626-35.
19. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4.
20. Watterson DM, Collinge M, Lukas TJ, et al. Multiple gene products are produced from a novel protein kinase transcription region. FEBS Lett. 1995;373:217-20.
21. Sarvazyan N. Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes. Am J Physiol. 1996;271:H2079-85.
22. Rabkin SW, Sunga P. The effect of doxorubicin (adriamycin) on cytoplasmic microtubule system in cardiac cells. J Mol Cell Cardiol. 1987;19:1073-83.
23. Kapelko VI. Myocardial fibrosis in cardiomyopathy: the possible crucial role in the dilative form. Exp Clin Cardiol. 2001;5:63-9.
24. Maisch B. Ventricular remodeling. Cardiology. 1996;87(suppl 1):2-10.
25. Lonn E, Factor SM, Van Hoeven KH, et al. Effects of oxygen free radicals and scavengers on the cardiac extracellular collagen matrix during ischemia-reperfusion. Can J Cardiol. 1994;10:203-13.
26. Rathore N, John S, Kale M, et al. Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat tissues. Pharmacol Res. 1998;38:297-303.
27. Qin F, Rounds NK, Mao W, et al. Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets. Cardiovasc Res. 2001;51:736-48.
28. Horenstein MS, Vander Heide RS, L'Ecuyer TJ. Molecular basis of anthracycline-induced cardiotoxicity and its prevention. Mol Genet Metab. 2000;71:436-44.
29. Pritsos CA, Ma J. Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity. Chem Biol Interact. 2000;127:1-11.
30. Ito H, Miller SC, Billingham ME, et al. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci U S A. 1990;87:4275-9.
31. Papoian T, Lewis W. Selective alterations in rat cardiac mRNA induced by doxorubicin: possible subcellular mechanisms. Exp Mol Pathol. 1991;54:112-21.
32. Jeyaseelan R, Poizat C, Baker RK, et al. A novel cardiac-restricted target for doxorubicin: CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J Biol Chem. 1997;272:22800-8.
33. Dalledonne I, Milzani A, Contini P, et al. Interaction of cardiac alphaactinin and actin in the presence of doxorubicin. Exp Mol Pathol. 1992;56:229-38.
34. Hein S, Kostin S, Heling A, et al. The role of the cytoskeleton in heart failure. Cardiovasc Res. 2000;45:273-8.
35. Dabiri GA, Turnacioglu KK, Sanger JM, et al. Myofibrillogenesis visualized in living embryonic cardiomyocytes. Proc Natl Acad Sci U S A. 1997;94:9493-8.
36. Hunter JJ, Chien KR. Mechanisms of disease: signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999;341:1276-83.
37. Kapelko V, Khatkevich A, Benevolensky D, et al. Cardiac pump function and mitochondrial respiration at early doxorubicin treatment and withdrawal. Exp Clin Cardiol. 1999;4:147-51.
38. Engedal H, Jensen H, Saetersdal TS. Ultrastructure of abnormal membrane inclusions in nuclei of human myocardial cells. Br Heart J. 1977;39:145-51.
39. Takemura G, Takatsu Y, Sakaguchi H, et al. Intranuclear mitochondria in human myocardial cells. Pathol Res Pract. 1997;193:305-11.
40. Unverferth BJ, Magorien RD, Balcerzak SP, et al. Early changes in human myocardial nuclei after doxorubicin. Cancer. 1983;52:215-22.
41. Lewis W, Galizi M, Puszkin S. Compartmentalization of adriamycin and daunomycin in cultured chick cardiac myocytes: effects on synthesis of contractile and cytoplasmic proteins. Circ Res. 1983;53:352-62.
42. Jeyaseelan R, Poizat C, Wu HY, et al. Molecular mechanisms of doxorubicin-induced cardiomyopathy: selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes. J Biol Chem. 1997;272:5828-32.